Join to View Full Profile
757 Westwood PlzB711 RrumcLos Angeles, CA 90095
Phone+1 310-267-9128
Dr. Wallace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 2011 - 2014- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Transitional Year, 2011 - 2012
University of Virginia School of MedicineClass of 2011
Clinical Trials
Publications & Presentations
PubMed
- 12 citationsEfficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance Therapy.Satoshi Motoya, Mamoru Watanabe, Kori Wallace, Andreas Lazar, Yasuko Nishimura
Inflammatory Intestinal Diseases. 2017-01-01 - 71 citationsInhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.David Q. Shih, Libo Zheng, Xiaolan Zhang, Hong Zhang, Yoshitake Kanazawa
Mucosal Immunology. 2014-05-21 - 384 citationsImmunopathology of inflammatory bowel disease.Kori Wallace, Libo Zheng, Yoshitake Kanazawa, David Q. Shih
World Journal of Gastroenterology. 2014-01-07
Press Mentions
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative ColitisJune 5th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
